Pipeline — registered trials by phase
Adjustment of Mask Pressure, for Bilevel Positive Airways Pressure Therapy, by Automated Algorithm
— · Respiratory Insufficiency, Sleep Disordered Breathing · Completed · est. 2015-02
AutoSet for Her Clinical Trial Protocol
— · Obstructive Sleep Apnea · Completed · est. 2013-06
Modified Adaptive Servoventilation (ASV) Compared to Conventional ASV
— · Periodic Breathing, Breathing-Related Sleep Disorder · Completed · est. 2011-09
Whitsundays (Nasal) Mask Take Home Study (90 Days)
— · Obstructive Sleep Apnea · Completed · est. 2023-11-06
Nasal Pillows vs. Nasal Masks at High CPAP Pressure
— · OSA · Completed · est. 2012-12
ASV Therapy for Insomnia
— · Insomnia, Insomnia (Moderate) · Recruiting · est. 2026-12
Evaluation of a Portable Device for Assessing Sleep Disordered Breathing in Congestive Heart Failure
— · Heart Failure, Congestive, Sleep Apnea Syndromes · Completed · est. 2009-04
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
— · Congestive Heart Failure, Left Ventricular Systolic Dysfunction · Completed · est. 2013-05
Development of Advanced Leak Detection Technologies for Positive Airway Pressure Devices Therapies
— · Obstructive Sleep Apnea (OSA) · Completed · est. 2021-03-12
Modified AutoSet Device vs Existing AutoSet Device, the Assessment of Efficacy and Subjective Comfort of the Treatment.
— · Sleep Apnea · Completed · est. 2009-06-15
INFORMing Patients With Oximetry Data to Improve MAD Engagement
— · Obstructive Sleep Apnea (OSA) · Not Yet Recruiting · est. 2026-12-01
Long-term Observation of PAP-therapy With Telemonitoring: Telemedicine Registry TelePAP
— · Obstructive Sleep Apnea, Central Sleep Apnea, Mixed Sleep Apnea · Completed · est. 2026-07-31
Investigation of Heart Failure Status Over Time Using Respiratory Parameters
— · Heart Failure, Congestive, Sleep Apnea Syndromes · Completed · est. 2010-03
Comparison of Modified With Conventional Adaptive Servoventilation Processes
— · Periodic Breathing, Cheyne-Stokes Respiration · Completed · est. 2009-09
Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure
— · Heart Failure, Sleep Disordered Breathing · Completed · est. 2015-04
Long-term Benefits of CPAP or MAD Treatment on the Sleep of OSAS Patients
— · OSA · Recruiting · est. 2022-10-15
Registry Study on Prescription, Patient Pathways, Therapy Efficacy and Usage of Mandibular Advancement Devices in Obstructive Sleep Apnea - PATT-OSA Registry
— · Obstructive Sleep Apnea · Active Not Recruiting · est. 2026-10-31
Reassure Device: Measurement Accuracy of Continuous Respiration Rate
— · Accuracy of Respiration Rate Measurement · Completed · est. 2015-07
Pediatric Nasal Mask Usability Study
— · Obstructive Sleep Apnea · Completed · est. 2011-07
PAP Systems Internal Clinical Studies (ICS)
— · Obstructive Sleep Apnea · Completed · est. 2024-07-22
Cardiovascular Responses in Congestive Heart Failure With Cheyne- Stokes Respiration
— · Heart Failure, Congestive, Cheyne-Stokes Respiration · Completed · est. 2010-03
Oran Park Mask External Clinical Study (3) Marketing Claims Study
— · Obstructive Sleep Apnea · Completed · est. 2023-11-20
GLYCOSA Study:Effect of PAP Treatment on Glycemic Control in Patients With Type 2 Diabetes
— · Diabetes Mellitus Type 2 · Completed · est. 2012-02
ApneaLink Air Home Sleep Testing (HST) Device Validation Study
— · Sleep-disordered Breathing · Completed · est. 2019-03-06
Evaluation of a Portable Oxygen Concentrator During Ambulation for Patients Who Require Supplemental Oxygen (POC-LEAN)
— · Chronic Obstructive Pulmonary Disease · Completed · est. 2020-03-09
AutoVPAP Versus VPAP; Assessment of Sleep and Ventilation
— · Chest Wall Disorder, Neuromuscular Disease · Completed · est. 2007-06
Performance of the Salt Lake Mask System
— · Obstructive Sleep Apnea · Completed · est. 2011-07
Astral VAPS AutoEPAP Clinical Trial
— · Upper Airway Obstruction, Respiratory Insufficiency, Respiratory Failure · Completed · est. 2017-03-01
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where ResMed is lead sponsor; 68 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- ARS2026-10-01Annual report to holders
- DEFA14A2026-10-01DEFA14A
- DEF 14A2026-10-01Proxy statement
- 8-K2026-09-01Current report (material event)
- 8-K2026-08-17Current report (material event)
- 10-K2026-08-13Annual report
- SCHEDULE 13G2026-08-07SCHEDULE 13G
- 8-K2026-08-06Current report (material event)
- 8-K2026-07-07Current report (material event)
- SCHEDULE 13G/A2026-07-01SCHEDULE 13G/A
- SD2026-05-26SD
- 10-Q2026-05-01Quarterly report
- 8-K2026-04-30Current report (material event)
- 8-K2026-04-30Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 10-Q2026-01-30Quarterly report
- 8-K2026-01-29Current report (material event)
- S-82025-11-21Employee stock plan
- S-82025-11-21Employee stock plan
- 8-K2025-11-20Current report (material event)
- 10-Q2025-10-31Quarterly report
- 8-K2025-10-30Current report (material event)
- SCHEDULE 13G/A2025-10-30SCHEDULE 13G/A
- ARS2025-10-02Annual report to holders
- DEFA14A2025-10-02DEFA14A
- DEF 14A2025-10-02Proxy statement
- 8-K2025-08-18Current report (material event)
- 10-K2025-08-08Annual report
- 8-K2025-08-01Current report (material event)
- 8-K2025-07-31Current report (material event)
- SD2025-05-29SD
- 10-Q2025-04-24Quarterly report
- 8-K2025-04-23Current report (material event)
- 10-Q2025-01-31Quarterly report
- 8-K2025-01-30Current report (material event)
- 8-K2024-11-21Current report (material event)
- DEFA14A2024-10-25DEFA14A
- 10-Q2024-10-25Quarterly report
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.